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Abstract. In a highland province of Burundi, indoor residual spraying and long-lasting insecticidal net distribution
were targeted in the valley, aiming also to protect the population living on the hilltops. The impact on malaria indicators
was assessed, and the potential additional effect of nets evaluated. After the intervention—and compared with the
control valleys—children 1–9 years old in the treated valleys had lower risks of malaria infection (odds ratio, OR: 0.55),
high parasite density (OR: 0.48), and clinical malaria (OR: 0.57). The impact on malaria prevalence was even higher in
infants (OR: 0.14). Using nets did not confer an additional protective effect to spraying. Targeted vector control had a
major impact on malaria in the high-risk valleys but not in the less-exposed hilltops. Investment in targeted and regular
control measures associated with effective case management should be able to control malaria in the highlands.
INTRODUCTION
Malaria outbreaks have been frequently reported in the
African highlands.1–3 Their occurrence has been attributed to
several factors, including climatic anomaly,2,4 land-use
changes,5 drug resistance,3,6 population migration,7 and
breakdown of both the local health system and vector control
activities.8 Different authors have shown that Anopheles den-
sity, malaria transmission, and corresponding human infec-
tions were higher and clustered around the breeding sites,9,10
particularly in the lowly endemic11 and epidemic-prone ar-
eas.12 Highlands’ hilly slopes13 and cold nights14 limit upward
dispersal of adult mosquitoes from the valleys, accentuating
their clustering.
During the last decade, malaria transmission in the Burun-
dian highlands steadily increased and resulted in a major epi-
demic in 2000. Within a few months (December 2000 to
March 2001), 2.9 million malaria cases were reported for a
population of 6.7 million. After this epidemic, prevention be-
came an absolute priority for the Burundi Ministry of Health
(MoH). However, because of political unrest, most vector
control activities (indoor residual spraying and insecticide-
treated nets) implemented in the lowlands15,16 and aimed at
controlling malaria have been stopped since 1992. Neverthe-
less, vector control activities were shown to be feasible in the
highlands and in the context of a complex emergency situa-
tion.17 Therefore, a 4-year vector control program was set up
in Karuzi, one of the highland provinces most affected by the
2000 malaria epidemic. This was targeted in time and in space,
run between 2002 and 2005, and consisted of an annual round
of indoor residual spraying (IRS) only at the bottom of the
valleys and 1 distribution in 2002 of long-lasting insecticidal
nets (LNs). Reductions of the vector population and the ma-
laria transmission have already been reported.18 We present
here the impact of these targeted vector control activities on
the prevalence of malaria infection.
METHODS
Study area and population. Karuzi is located in the central
plateau of Burundi at an altitude of 1450–2000 m. It is a hilly
province with a surface of 1457 km2 and an estimated popu-
lation of 302,062 inhabitants (EPISTAT: Epidemiology and
Statistics Cell Burundi, 2002).19 The annual average tempera-
ture is 19°C with the coolest season recorded in June–July and
the hottest in September–October. There are 2 rainy seasons,
from September to December and from January to May, with
an average annual rainfall of 1160 mm. According to the
MoH, malaria in the high plateau is hypo- to meso-endemic
and prone to epidemics. An increase of malaria cases is usu-
ally observed at the end of the 2 rainy seasons, and recent
epidemics occurred after the second one (EPISTAT data-
base).19 In 2002, malaria was responsible for ∼60% of the
total outpatient attendances in Karuzi (MSF-B database,
2002).20 Anopheles gambiae sensu stricto (s.s.) and Anopheles
funestus are the main vectors.18
Study design. Vector control activities were described in a
previous study.18 Briefly, 4 zones were identified in this study:
(1) intervention-treated valleys (population of 67,187 and
area of 264 km2), (2) corresponding intervention-nontreated
hilltops (51,161 inhabitants; 201 km2), (3) unsprayed control
valleys (11,744 inhabitants; 50 km2), and (4) control hilltops
(10,709 inhabitants; 55 km2). In treated valleys, 1 annual IRS
round was performed in June–July using deltamethrin 5WP
(in 2002–2004) or alphacypermethrin 5WP (in 2005) at a con-
centration of 25 mg of active ingredient/m2. IRS coverage
exceeded 90%, except in 2002 (86%). LNs (PermaNet 1.0)
were distributed in 2002, before the first IRS round on the
basis of 2 LNs per sprayed house. Intervention areas corre-
spond to large valleys with many irrigation fields and high
population density. The control areas were smaller and were
selected to enable the evaluation of the vector control inter-
vention. In both intervention and control areas, people had
access to antimalarial treatment. Nine cross-sectional studies
were performed. The first was carried out before the start of
the vector control activities to provide baseline data. Then, 2
yearly surveys were carried out, 3 and 9 months after each
annual IRS round. The study was designed to have by survey
80% power to detect 20% difference in malaria prevalence
* Address correspondence to Natacha Protopopoff, Department of
Parasitology, Institute of Tropical Medicine, Nationalestraat 155,
B-2000 Antwerp, Belgium. E-mail: nprotopopoff@itg.be
Am. J. Trop. Med. Hyg., 79(1), 2008, pp. 12–18
Copyright © 2008 by The American Society of Tropical Medicine and Hygiene
12
between intervention and control areas, with 95% confidence,
assuming a design effect of 2 and a prevalence of 40% in the
control group. A random cluster-sample design was used for
every survey. The selection of houses was detailed in a pre-
vious paper.18 Totals of 450 houses in Survey 1, 600 houses in
Survey 2, and 800 houses for Surveys 3–9 were selected. All
members of the household were enumerated, and 2 individu-
als—one between ages 1 and 9 and one over age 9—were
chosen at random, irrespective of any clinical symptoms.
When a selected person was not present on the survey day,
another appointment was made. Entomological evaluations
were carried out in the same houses, and results have been
presented elsewhere.18
Thick and thin blood smears were collected and stained
with Giemsa (5% for 20 minutes). Parasite density was de-
termined on the basis of the number of parasites per 200
white blood cells (WBC), assuming a total WBC count of
8000/L. Thin blood films were used to confirm species iden-
tification. Quality control was done on 10% of the slides of
each survey. When the discrepancy was more than 5%, all
slides were re-read. A rapid diagnostic test (RDT; Paracheck-
Pf) was also used. Individuals found to be positive by the
RDT were treated according to MoH guidelines [in 2003, 30
mg oral quinine per kg body weight over 7 days; from 2004
onward, artesunate (5 mg/kg/day) and amodiaquine (10 mg/
kg/day) for 3 days]. The axillary temperature was measured.
A short questionnaire to collect data on age, sex, net use,
malaria attacks, and treatment history during the past 2
months was administered.
To estimate malaria incidence after 3 IRS rounds, infants
1–11 months old were included in Survey 6. In this study, all
infants were recruited in the selected houses to reach a num-
ber of 8. When the number of infants was not sufficient, ad-
ditional closest houses were sampled to reach the required
number of infants.
Statistical analysis. The following malariometric indices
were evaluated: (1) history of malaria-like illness and (2) ma-
laria treatment during the past 2 months, (3) prevalence of
malaria infection (proportion of positive blood smears for
malaria parasites, both sexual and asexual forms), (4) preva-
lence of high-density parasitemias (proportion of blood
smears with more than 5000 parasites/L among the total
number of slides examined), and (5) prevalence of clinical
malaria defined as malaria infection and fever (axillary tem-
perature  37.5°C).
The data were analyzed using the survey logistic regression
in Stata 9.2 (Stata Corp., College Station, TX), taking into
account the study design. A cluster is a group of 4–8 houses,
according to surveys and areas. Malaria indicators were ana-
lyzed by age group (1–9 and > 9 years) for valleys and hilltops.
The malaria indices were first compared between untreated
valleys and hilltops (Table 1). Baseline data on population
characteristics and malaria indicators in the 4 zones were
summarized with proportions or means (Table 2). The preva-
lence of infection was analyzed using the following indepen-
dent variables: survey identification, intervention versus con-
trol, and their interaction terms (Table 3). A multivariate
regression logistic was used to assess the effect of using a net
and living in a sprayed valley on prevalence, clinical malaria,
and high-density parasitemias (Table 4). Finally, analyses of
malaria infection in 1- to 11-month-old infants were done in
valleys and control areas with intervention versus control as
the main independent variables. This bivariate model in-
cluded also age as a potential confounder.
Ethics. The Ethics Committee of the Institute of Tropical
Medicine, Antwerp, approved the study. At the time of the
implementation of the program and surveys, the Institutional
Ethical Committee was not functional in Burundi. However,
the Ministry of Health signed an agreement for the vector
control program and the study design and the National Ma-
laria Control Program (LMTC) offered close collaboration.
Informed consent was obtained for the individuals or their
parents included in the survey. In case of refusal, other houses
were selected.
RESULTS
Malaria in Karuzi. In the untreated zones (all the selected
zones except the intervention valley in Surveys 2–9), children
5–19 years old had the highest prevalence of malaria infec-
tion, while individuals over age 50 had the lowest (20.2%).
Malaria prevalence was lower in the hilltops than in the val-
leys but followed a similar trend (Figure 1). Plasmodium fal-
ciparum was the predominant species (85.2%, 2891/3393), fol-
lowed by Plasmodium malariae (6.7%, 228/3393) and Plas-
modium ovale (0.5%, 15/3393), with the remaining 7.6% (259/
3393) being mixed infections. This distribution was almost
constant throughout the surveys.
The proportion of individuals to declare a history of ma-
laria-like illness, to have used antimalarial treatment, to be
TABLE 1
Malaria indices and risk (odds ratio) in untreated valleys (NT-V, valleys of Survey 1 and control valleys of Surveys 2–9) compared with untreated
hilltops (NT-H, intervention and control hilltops of all surveys)
NT-V NT-H OR (95% CI) P value
Age group  9 years
% History of malaria-like illness (N) 62.3 (1123) 48.3 (2172) 1.8 (1.5–2.2) < 0.001
% Used malaria treatment (N) 27.9 (1122) 22.7 (2172) 1.3 (1.1–1.6) 0.011
% Prevalence (N) 52.6 (1072) 27.3 (2090) 3.0 (2.4–3.7) < 0.001
% High-density parasitemias (N) 11.0 (1061) 5.0 (2079) 2.4 (1.7–3.2) < 0.001
% Clinical malaria (N) 14.0 (1068) 6.2 (2087) 2.4 (1.8–3.3) < 0.001
Age group > 9 years
% History of malaria-like illness (N) 68.3 (1620) 59.9 (3166) 1.4 (1.2–1.7) < 0.001
% Used malaria treatment (N) 30.5 (1620) 26.3 (3165) 1.2 (1.0–1.5) 0.029
% Prevalence (N) 43.1 (1545) 26.0 (3025) 2.2 (1.8–2.6) < 0.001
% High-density parasitemias (N) 4.9 (1533) 3.0 (3004) 1.7 (1.2–2.3) 0.003
% Clinical malaria (N) 12.6 (1544) 7.4 (3024) 1.8 (1.4–2.3) < 0.001
All P values and 95% confidence intervals (CI) were determined taking clustering into account.
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infected with high parasite density, and to have clinical ma-
laria at the time of the survey was significantly higher in the
valleys than in the hilltops (Table 1). These differences were
seen in both age groups but were the highest in children under
age 9.
Pre-intervention result. About 776 people were selected for
Survey 1 (1–9 years old, 316; > 9 years old, 458), and among
them 129 (16.6%) were absent. About half of the missing
people (52.1%) were male in the age group 1–9 years, and
this proportion is 36.7% in the older age group. For Surveys
2–9, the number of missing people was much lower, at 6.0%
(611/10,127).
In the valleys, the demographic characteristics and the ma-
lariometric indices were similar in control and intervention
areas (Table 2). In the hilltops, however, some differences
were observed in terms of history of malaria-like illness and
TABLE 3
Prevalence of malaria infection in children ages 1–9 years and over 9 years, observed by surveys and by areas in the valleys, with risk (odds ratio)
of infection in intervention relative to control valleys
 9 Years > 9 Years
Prevalence (N) OR (95% CI) P value Prevalence (N) OR (95% CI) P value
Survey 2
Control 64.1% (39) 1 0.789 44.1% (59) 1 0.520
Intervention 61.1% (113) 0.88 (0.34–2.28) 38.2% (191) 0.79 (0.38–1.64)
Survey 3
Control 64.7% (119) 1 0.040 51.7% (178) 1 0.033
Intervention 44.2% (86) 0.43 (0.19–0.96) 35.8% (123) 0.52 (0.27–0.95)
Survey 4
Control 59.2% (130) 1 0.091 45.4% (196) 1 0.048
Intervention 42.5% (134) 0.51 (0.23–1.11) 32.3% (192) 0.57 (0.33–0.99)
Survey 5
Control 52.2% (136) 1 0.003 47.6% (185) 1 0.006
Intervention 28.5% (137) 0.36 (0.19–0.71) 26.9% (186) 0.41 (0.21–0.77)
Survey 6
Control 38.2% (136) 1 0.105 33.3% (204) 1 0.033
Intervention 26.0% (123) 0.57 (0.29–1.13) 20.8% (192) 0.53 (0.29–0.95)
Survey 7
Control 47.7% (128) 1 0.063 40.8% (184) 1 0.218
Intervention 31.7% (123) 0.51 (0.25–1.04) 31.7% (183) 0.67 (0.36–1.26)
Survey 8
Control 41.4% (133) 1 0.213 35.1% (185) 1 0.584
Intervention 30.6% (134) 0.63 (0.30–1.31) 31.9% (182) 0.86 (0.51–1.46)
Survey 9
Control 57.9% (133) 1 0.049 49.7% (191) 1 0.005
Intervention 39.4% (134) 0.47 (0.22–1.0) 33.5% (200) 0.51 (0.32–0.82)
All P values and 95% confidence intervals (CI) were determined taking clustering into account. Odd survey numbers: April–May, 9 months after the annual IRS round. Even survey numbers:
November–December, 3 months after the annual IRS round.
TABLE 2
Baseline demographic characteristics and malaria indices in the intervention and control areas (Survey 1)
Valleys Hilltops
Control Intervention Control Intervention
Population 11,744 67,187* 10,709 51,163
Area (km2) 50 264 55 201
Age group  9 years N  64 N  54 N  57 N  93
Mean age in years 6.1 (5.4–6.7) 5.6 (4.8–6.4) 6.1 (5.4–6.8) 5.3 (4.7–5.8)
% Males 46.9 (34.5–59.2) 59.3 (44.3–74.2) 49.1 (34.6–63.7) 55.9 (43.9–67.9)
% Sleeping under a net 3.1 (0.0–9.1) 14.8 (0.0–30.8) 0 – 25.8 (10.6–41.0)
% History of malaria-like illness 89.1 (80.8–97.4) 81.5 (72.2–90.7) 82.5 (70.4–94.5) 62.4 (51.2–73.5)
% Used malaria treatment 59.4 (42.3–76.5) 46.3 (29.5–63.1) 43.9 (24.6–63.1) 37.6 (25.6–49.7)
% Prevalence 51.6 (37.9–65.2) 66.7 (55.8–77.5) 33.3 (16.9–49.8) 38.7 (23.5–54.0)
% Clinical malaria 9.51 (1.5–17.6) 13.22 (1.8–24.6) 10.5 (0.0–21.0) 12.9 (3.7–22.1)
% High-density parasitemias 3.23 (0.0–7.5) 9.3 (1.3–17.2) 10.74 (0.0–21.2) 12.25 (4.0–20.5)
Age group > 9 years N  79 N  84 N  80 N  136
Mean age in years 32.9 (28.3–37.6) 36.3 (32.8–39.8) 36.3 (31.9–40.8) 32.8 (30.0–35.5)
% Males 43.0 (34.2–51.8) 26.2 (16.1–36.3) 43.8 (33.9–53.6) 39.7 (31.0–48.5)
% Sleeping under a net 2.5 (0.0–7.5) 16.7 (3.5–29.9) 0 – 21.3 (8.7–33.9)
% History of malaria-like illness 86.1 (76.9–95.2) 79.8 (69.5–90.0) 90.0 (84.1–95.9) 65.4 (54.7–76.2)
% Used malaria treatment 58.2 (44.5–72.0) 57.1 (45.1–69.2) 57.5 (44.1–70.9) 42.6 (33.1–52.2)
% Prevalence 48.1 (37.1–59.1) 35.7 (21.7–49.7) 32.5 (21.3–43.7) 30.9 (22.8–39.0)
% Clinical malaria 6.3 (1.0–11.7) 3.6 (0.0–7.4) 10.0 (3.1–16.9) 2.9 (0.0–5.6)
% High-density parasitemias 6.96 (1.3–12.4) 3.6 (0.0–7.4) 7.67 (1.0–14.2) 4.48 (1.3–7.5)
Mean and proportion are presented with their 95% confidence intervals (95% CI). All 95% CI were determined taking clustering into account.
* The population in the intervention valleys was collected during a census done before Survey 1; the other numbers were estimated from data given by the administration.
N  163, 253; some parasite densities were missing.
N  362, 456, 590, 673, 779, and 8135; some temperatures were missing.
PROTOPOPOFF AND OTHERS14
clinical malaria for the age group > 9 years. The proportion of
people sleeping under a bed net was higher in the interven-
tion areas. Most of the hills in the intervention areas were
considered to be at high risk during the 2000 epidemic, and
these households received LNs in 2001.17 The overall parasite
prevalence during Survey 1 was 40.2% (260/647): 17.9% (44/
246; parasite counts were not done for 14 slides) had a high
parasite density, and 19.7% (51/259; 1 body temperature data
point was missing) had fever.
Post-intervention result. When intervention with control
valleys were compared, children of age 1–9 years had a sig-
nificantly lower risks of malaria infection [OR: 0.55, 95%
confidence interval (CI): 0.42–0.72, P < 0.001], high-density
parasitemias (OR: 0.48, 95% CI: 0.33–0.70, P < 0.001), and
clinical malaria (OR: 0.57, 95% CI: 0.41–0.81, P  0.001).
Furthermore, histories of malaria illness (OR: 0.66, 95% CI:
0.52–0.83, P < 0.001) and antimalarial drug use (OR: 0.65,
95% CI: 0.49–0.85, P  0.002) were lower in the intervention
valleys compared with the control valleys. The impact of the
intervention in the older age group was also significant but
less pronounced for all of these outcomes. According to sur-
veys, malaria prevalence was reduced in intervention valleys
compared with control valleys by 12–64% in the  9 age
group and by 14–59% in > 9 age group (Table 3). These dif-
ferences were significant in children 9 years old for Surveys
3, 5, and 9 and in individuals > 9 years old for Surveys 3–6 and
9. No difference in malaria prevalence was observed between
intervention hilltops and control hilltops (results not shown).
Use of LNs, based on individual declaration of sleeping the
previous night under a LN, ranged between 70.2% (217/309)
for Survey 2 to 18.5% (61/330) for Survey 9. LNs use was
relatively high until Survey 6 (57.7%) and dropped below
36% afterward. When all survey results were combined, the
relative impact of IRS and net use varied according to age
group, season (9 months after IRS and 3 months after IRS),
and malaria indicators (Table 4). Three months after the in-
tervention, living in a sprayed valley significantly reduced
prevalence, clinical malaria, and high-density parasitemias
compared with houses located in control valley in all age
groups, except for clinical malaria, in the > 9 age group.
Sleeping under a net did not decrease any of the malaria
indicators adjusted for spraying. Nine months after the inter-
vention, when the residual effect of the insecticide used for
IRS has ceased, prevalence was still lower in houses located in
sprayed valleys for both age groups and also for high para-
sitemias in children 1–9 years old.
The prevalence of malaria infection among the infants ex-
amined during Survey 6 was 4.6% (33/711), with 24.2% (8/33)
having fever and 33.3% (11/33) high-density parasitemias.
Malaria prevalence was significantly lower in the intervention
valleys than in the control valleys (OR: 0.14, 95% CI: 0.04–
0.52, P  0.005). No difference was observed between inter-
vention hilltops and control hilltops (Table 5). Infants treated
for malaria before the survey were significantly fewer in num-
FIGURE 1. Age-specific malaria prevalence in untreated valleys
(NT-V, valleys of Survey 1 and control valleys of Surveys 2–9) and
hilltops (NT-H, intervention and control hilltops of all surveys).
TABLE 4
Impact of Indoor Residual Spraying and sleeping under a net on malaria prevalence, clinical malaria, and high-density parasitemias, 3 and 9
months after intervention in the valley (multivariate logistic regression used)
Prevalence Clinical malaria High-density parasitemias
OR* (95% CI) P value OR* (95% CI) P value OR* (95% CI) P value
3 months after intervention
1–9 years
Sleeping under net vs. not 1.21 (0.85–1.72) 0.298 1.10 (0.57–2.13) 0.766 1.09 (0.41–2.89) 0.862
House in sprayed valley vs. not 0.65 (0.42–0.99) 0.046 0.51 (0.26–0.98) 0.045 0.35 (0.16–0.79) 0.011
> 9 years
Sleeping under net vs. not 1.0 (0.76–1.34) 0.977 0.82 (0.49–1.39) 0.468 1.19 (0.50–2.85) 0.688
House in sprayed valley vs. not 0.71 (0.52–0.97) 0.034 0.64 (0.37–1.10) 0.106 0.38 (0.18–0.78) 0.009
9 months after intervention
1–9 years
Sleeping under net vs. not 0.88 (0.60–1.31) 0.536 0.95 (0.57–1.57) 0.830 0.88 (0.48–1.62) 0.687
House in sprayed valley vs. not 0.45 (0.30–0.69) < 0.001 0.63 (0.39–1.02) 0.059 0.61 (0.38–0.99) 0.045
> 9 years
Sleeping under net vs. not 0.84 (0.61–1.15) 0.271 0.66 (0.41–1.07) 0.091 0.62 (0.31–1.27) 0.191
House in sprayed valley vs. not 0.55 (0.40–0.74) < 0.001 0.74 (0.48–1.13) 0.156 1.03 (0.59–1.80) 0.916
* Odds ratio (OR) adjusted for IRS and sleeping under a net.
TABLE 5
Malaria prevalence and risk of malaria infection in infants 1–11
months old by area (Survey 6)
n/N* Prevalence OR† (95% CI) P value
Valley
Control 17/161 10.6% 1 0.005
Intervention 3/189 1.6% 0.14 (0.04–0.52)
Hilltop
Control 6/182 3.9% 1 0.797
Intervention 7/179 3.3% 1.19 (0.30–4.74)
* n/N, number of positive slide/number examined.
† OR adjusted for age; all P values and CI were determined taking clustering into account.
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ber in the intervention valleys (3.7%, 7/189) than in control
valleys (9.9%, 16/161; OR: 0.35, 95% CI: 0.13–0.91, P 
0.039).
DISCUSSION
In Africa, the spatial distributions of malaria have been
extensively studied in low endemic and epidemic-prone areas,
and focal vector control activities have been recom-
mended.10,11,14,21 In Karuzi, vector control activities was
based on 1 distribution of LNs and a yearly round of IRS
targeting the valleys, before the main transmission season.
This was justified by the observation that 90% of malaria
transmission occurred in the valleys.18 Moreover, the baseline
study showed that children are indeed 3 times more at risk for
a malaria infection in the valleys compared with the hilltops.
Although control areas were similar to intervention areas
in term of demographic characteristics and malaria indices,
bednet use was higher in the intervention areas before the
start of the operations. The choice of the intervention areas
was made on the basis of the perceived risk for epidemic, i.e.,
the intervention valleys were considered to be more at risk
than those selected as control areas. During the baseline
study, malaria transmission was 15 times lower in the control
compared with the intervention valleys.18 Despite this differ-
ence and with a drop of infectious bites from 5.1 to < 0.5 per
house per month after the first intervention round,18 we were
able to show a significant reduction of all malaria indices in
the intervention valleys compared with control valleys. In a
holoendemic area of Kenya, frequency of exposure to sporo-
zoite-infected mosquitoes was correlated to malaria infection
but even more to the high parasitemias.22,23 It has been con-
cluded that reduction in high parasite densities would reduce
malaria morbidity and mortality.22 These results are in agree-
ment with our findings, where the most important impact was
found on high parasitemias. The effect was even greater in
children  9 years old, possibly because of their lower immu-
nity. The impact of the intervention tended to decrease in the
fourth year and could be linked to a relative increase of An.
gambiae s.s. density in the intervention valleys, although not
as high as in the control areas.18
The impact of the vector control activities on malaria
prevalence was particularly important in infants, with an 86%
decrease in risk of malaria infection. This is a strong indica-
tion that malaria transmission was drastically reduced by the
intervention, as these infants were born after its implemen-
tation. Prevalence of malaria infection in the whole popula-
tion, and more particularly of asymptomatic carriers, was
higher than expected for an area defined as low transmission
and epidemic prone. The high prevalence of asymptomatic
infections suggests a change to a higher level of endemicity. In
such a changing situation, malaria prevalence among infants
is than a more appropriate indicator of impact of ITN23 or
IRS.24
During the first 2 years of the intervention, the first-line
treatment was sulfadoxine–pyrimethamine (SP), later re-
placed by an artemisinin-based combination therapy (ACT)
because of high SP resistance,26 ACT use should improve
cure rates, decrease gametocyte carriage, and may reduce ma-
laria transmission where this is unstable.27,28 In the control
areas of Karuzi, malaria transmission was higher after ACT
implementation,18 despite more than 20% of the study popu-
lation having taken an antimalarial treatment. One reason
could be the unreliability of the treatment history by the study
population, i.e., antimalarial treatment would not be as fre-
quent as estimated by the survey. However, another reason
could be that asymptomatic individuals would maintain a suf-
ficiently large gametocyte reservoir that was able to compen-
sate for the potential reduction of transmissibility in the
treated patients. In our study, the observed decrease of ma-
laria indices in the intervention areas can be largely attributed
to vector control activities as no influence of ACT on malaria
transmission could be detected.
No additional protection by LNs use was observed on any
of the malaria indicators 3 months after the intervention. The
absence of impact on malaria morbidity of LNs when imple-
menting IRS was also observed in Eritrea,29 while a mutually
additive effect has been reported in Equatorial Guinea.30
However, in Equatorial Guinea the IRS coverage was only
77% compared with more than 90% obtained in Karuzi.
When IRS coverage is high, the additional benefit of treated
nets is limited, as shown by the entomological surveys where
malaria transmission was already being reduced to an unde-
tectable level after spraying.18
The upper altitude limit for malaria in the African high-
lands has risen in past decades, and formerly malaria-free
areas have become epidemic prone.2,4,31 The spread of the
vectors’ distribution in time and space expose the local popu-
lations to a longer transmission season, which results in an
increased endemicity in the highlands.7,32 In Burundi, at the
beginning of the century the central plateaus were declared
malaria-free, and then epidemics were reported.5,33,34 In
Karuzi, the high prevalence in children 2–9 years old (32.1–
53.4% in control areas) and the high proportion of asymp-
tomatic carriers show that malaria has become mesoendemic,
with a more stable transmission. In epidemic-prone areas,
emphasis has been put in malaria early warning systems and
early detection systems,35,36 and it was argued that regular
vector control measures may be a waste of resources in these
areas.37 However, regarding the spread of malaria in most
highland areas, regular vector control activities targeted to
the high-risk areas could be more cost-effective than less-
effective emergency interventions that often face delays in
mobilization.17
The IRS activities in Karuzi were stopped at the end of the
study, despite ongoing transmission. ACT use alone is un-
likely to maintain the reduction in malaria incidence without
being associated with preventive measures. In present study,
targeted IRS was shown to be very effective to prevent high-
land malaria and this mainly because of the high coverage. In
African highlands, IRS has the advantage of targeting the
places of highest risk38 (i.e., the valleys). However, effective
implementation of IRS relies on highly professional vector
control services, good planning and timing of the activities,
and strict management and logistics support.39,40 There is an
urgent need to build up this capacity in many places. ITNs,
especially if they are long-lasting, have the advantage of being
less demanding to implement than IRS and of being able to
be targeted at individuals most at risk.41 As full coverage is
essential to impact transmission, both methods can be com-
bined if full coverage with IRS is difficult to achieve or sustain
over time. Moreover, the combination of IRS and ITN could
permit better management of insecticide resistance if unre-
lated insecticides are used.42 Investment in targeted and regu-
PROTOPOPOFF AND OTHERS16
lar vector control measures associated with effective case
management could have a major impact on malaria morbidity
in the African highlands.
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